SCHEMBL20511745

SCHEMBL20511745

N#Cc1cccc(COC(=O)n2ccnc2)n1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
MGLL Q99685 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TBXAS1 P24557 1/20 0.34
ALDH1A1 P00352 1/20 0.34
AOC3 Q16853 1/20 0.34
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
FAAH O00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973954 0.81 DPP4 (0.43) LMNAMAPK1CYP1A2CYP3A4TBXAS1
SCHEMBL26597451 0.80 HDAC1 (0.34) LMNAMAPK1MGLLTBXAS1ALDH1A1
SCHEMBL19973982 0.79 CYP24A1 (0.35) CYP19A1L3MBTL1LMNATBXAS1ALDH1A1
SCHEMBL20511767 0.78 MAOB (0.40) CYP1A2CYP2C19TBXAS1
SCHEMBL20511958 0.77 CYP19A1 (0.44) CYP19A1CYP11B1CYP11B2L3MBTL1TBXAS1
SCHEMBL12016593 0.77 CYP19A1 (0.56) CYP19A1CYP11B1CYP11B2LMNAMAPK1
SCHEMBL20509607 0.76 PDE10A (0.47) CYP1A2
SCHEMBL19973543 0.76 SMN1; SMN2 (0.50) LMNAMAPK1CYP1A2CYP3A4CYP2D6
SCHEMBL9298287 0.76 ALDH1A1 (0.42) CYP1A2CYP2C19ALDH1A1AOC3
SCHEMBL12016592 0.75 CYP19A1 (0.51) CYP19A1CYP11B1CYP11B2L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3601216-B1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION ARBUTUS BIOPHARMA CORP (CA) 2023-10-25 EP disclosed
EP-3601216-B1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION ARBUTUS BIOPHARMA CORP (CA) 2023-10-25 EP disclosed
EP-3601216-A1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2020-02-05 EP disclosed
WO-2018172852-A1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2018-09-27 WO disclosed